StockVS

So-Young International Inc. (SY) Análise de ações

Saúde

So-Young International Inc.

$2.20

$-0.03 (-1.35%)

Última atualização: 26 de maio de 2026

Histórico de Preços

Análise

Visão geral da empresa

So-Young International Inc. operates an online platform dedicated to providing consumption healthcare services within the People's Republic of China, offering a mobile application that grants users access to medical aesthetic knowledge, community support, and reservation options for treatments with medical professionals. The company functions within the Healthcare sector, specifically in the Health Information Services industry, positioning itself at the intersection of digital connectivity and consumer medical needs. Its current scale is defined by a market capitalization of $287.62M and annual revenue reaching $1.52B, while specific employee count data is not publicly disclosed in the available records. These valuation and revenue figures indicate that the entity represents a mid-to-large-sized enterprise attempting to capture significant market share in the rapidly expanding Chinese aesthetic healthcare market, leveraging a digital-first approach to deliver services.

Saúde financeira

So-Young International Inc. reported revenue of $1.52B over the trailing twelve months, yet this gross inflow was accompanied by a net income loss of $242,300,992 and an EBITDA loss of $220,548,992. The substantial gap between the $1.52B revenue and the negative net income reveals a highly aggressive cost structure where operating expenses, likely driven by technology infrastructure and customer acquisition costs, significantly erode profitability at this stage of development. While the company reports negative free cash flow metrics, its balance sheet holds $871.68M in cash against $299.71M in debt, suggesting a robust liquidity position despite current earnings deficits. The company maintains a debt-to-equity ratio of 17.96, which indicates a highly leveraged capital structure relative to its equity base, relying heavily on financial leverage to fund operations or expansion. Short-term liquidity appears stable with a current ratio of 1.89, implying the firm possesses sufficient current assets to cover its short-term liabilities nearly twice over. Return on Equity stands at -13.6% and Return on Assets is -6.2%, metrics that collectively reveal that management is currently generating negative returns on the capital invested by shareholders and the total asset base, a common characteristic for high-growth firms prioritizing expansion over immediate profit generation.

Avaliação de valorização

The valuation metrics present a complex picture, with a trailing P/E ratio marked as N/A due to the negative earnings, while the forward P/E is listed at -11.76, reflecting the expectation that earnings may remain negative in the near term. The price-to-book ratio sits at 1.28, indicating that the market values the company at a modest premium of 28% over its tangible book value, suggesting investors are willing to pay more for the enterprise based on its assets alone. Alternative valuation measures include a price-to-sales ratio of 0.19 and an EV/EBITDA of 1.07, figures that suggest the market is pricing the stock at a fraction of its sales revenue, often a valuation method used for companies with negative earnings where traditional multiples are less applicable. The stock has exhibited significant volatility, trading within a 52-week range bounded by a high of $6.28 and a low of $0.67, with the current trading price situated relatively close to the bottom of this historical range given the low price-to-sales multiple. The company carries a beta of 2.17, a figure that signifies high price volatility, as the stock's price tends to fluctuate with a magnitude more than double that of the broader market benchmark.

Growth & Income

So-Young International Inc. demonstrates robust revenue growth of 24.8% year-over-year, whereas earnings growth is listed as N/A due to the company's current loss-making status. Since earnings are negative, they are technically not growing faster than revenue in a traditional sense, but rather the company is expanding its top line while still managing to cover its massive operational burn rate. As a non-dividend payer, the company currently maintains a dividend yield of N/A and a payout ratio of 0.0%, indicating that it does not distribute profits to shareholders because it generates no net income to distribute. Instead of paying dividends, the firm retains its cash reserves, utilizing the $871.68M in cash to fund its operations and potentially finance future growth initiatives rather than returning capital to investors. This profile highlights a classic high-growth, high-risk investment pattern where capital is reinvested into the business model to achieve profitability, rather than providing immediate income to shareholders.

Comparação com pares

So-Young International Inc. (SY) atua no setor de Serviços de Informação de Saúde. Veja como se compara com seus pares mais próximos por capitalização de mercado:

Empresa Ticker Cap. de Mercado Índice P/L
So-Young International Inc. SY $220.66M N/A
Veeva Systems Inc. VEEV $25.87B 29.1
BrightSpring Health Services, Inc. BTSG $11.70B 78.3
Tempus AI, Inc. TEM $8.38B N/A

O índice P/L médio do setor Serviços de Informação de Saúde é 57.5x. So-Young International Inc. é negociada a um P/L de N/A.

Esta análise é gerada por IA apenas para fins informativos e não constitui aconselhamento financeiro. Os dados podem estar atrasados ou imprecisos. Sempre faça sua própria pesquisa e consulte um consultor financeiro qualificado antes de tomar decisões de investimento.

Sobre So-Young International Inc.

So-Young International Inc. operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users access to medical aesthetic knowledge, community support and reservation options for treatment with medical professionals, and medical aesthetic institutions; Weixin mini program to explore treatment options, check prices, schedule appointments, participate in online consultations, and track follow-ups; and medical aesthetic community content through its website soyoung.com. Its aesthetic centers offer non-invasive to minimally invasive procedures, including device-based options, such as thread lifts, intense pulsed light, ultrasound facelifts, picosecond lasers, and body contouring treatments, as well as injectable treatments, including skin boosters, hyaluronic acid-based products, botox, and type I and type III collagen. In addition, the company engages in the research and development, production, sale, and distribution of light therapy devices, including excimer laser systems, UV excimer therapy devices, LED and red-light therapy systems, and advanced laser and intense pulsed light technologies; surgical laser devices, including carbon dioxide laser machines, multi-wavelength and semiconductor laser systems for urological treatments, and hydrodynamic-assisted liposuction systems for plastic surgery, as well as pneumatic liquid spray devices skin cleansing. Further, it offers injectable products; sales and technical, maintenance, installation, operational training, error reporting, maintenance, and equipment packaging services; consumption healthcare services, including dermatology, dentistry and orthodontics, physical examinations, gynecology, and postnatal care; reservation services; and content management through beauty diaries, short-form videos, treatment reviews, featured articles, and chat messages. The company was founded in 2013 and is headquartered in Beijing, China.

A descrição da empresa é mostrada em inglês.

Visitar site →

Estatísticas Principais

Capitalização
$220.66M
Índice P/L
N/A
Máx. 52 Sem.
$6.28
Mín. 52 Sem.
$0.83
Volume Médio
530.70K

Dados fornecidos pelo Yahoo Finance via yfinance. Atualizado diariamente.

Informações da Empresa

Bolsa
NASDAQ
País
China
Funcionários
2,348